The Department of Public Health and Social Services (DPHSS) has issued a voluntary recall alert for select lots of Bicillin® L-A (Penicillin G Benzathine Injectable Solution) manufactured by King Pharmaceuticals LLC, a subsidiary of Pfizer. The recall follows the discovery of particulates during routine visual inspections, which pose serious health risks if injected—ranging from tissue inflammation and damage to life-threatening complications like embolism.

DPHSS’s Division of Environmental Health (DEH) has confirmed through recall effectiveness checks that the affected products were distributed and sold by ExpressMed Pharmacy. Corrective actions were immediately implemented to remove the impacted items from store shelves, and ExpressMed is working directly with the manufacturer on product returns and proper disposal.

At this time, no local adverse health reports linked to the affected Bicillin® L-A lots have been received. However, consumers who believe they may have been administered the recalled product and are experiencing any side effects are urged to contact their primary healthcare provider.

For recall-related inquiries:

Pfizer Medical Information: 800-438-1985, Option 3 (Mon–Fri, 9 AM–5 PM ET)

Pfizer Drug Safety (Adverse Event Reporting): 800-438-1985, Option 1 (24/7)

Online: www.pfizermedinfo.com

For local concerns, contact DPHSS DEH Consumer Commodities Program at (671) 300-9579.